In-Plant Training Program At SK+F Eskayef Bangladesh Ltd. Introduction SK+F symbolizes a name-a state of mind. From the inception in 1990, it has today burgeoned into one of the top line conglomerates in Bangladesh. Eskayef Bangladesh Limited, the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1990 and is now on its way to becoming a high performance global player. Eskayef Bangladesh Limited is an organization with equal emphasis on Leadership, Technology, Quality & Passion. Eskayef Bangladesh Limited is the leading generic pharmaceutical manufacturer in Bangladesh producing quality essential and other ethical drugs & medicines. Eskayef Bangladesh Limited has three GMP compliant formulation plants. The Tongi unit plant started its operation to meet challenges of globalization & to expand export horizon. Tongi plant is situated at Tongi, Gazipur. It is constructed as per the requirement of the UK MHRA. All the facilities and equipment have been designed and built to ensure cGMP compliance. All facility is an excellent blend of modern architecture, advanced technology, quality assurance and professionalism. It enjoys its brilliant is the prominent Drag manufacturing company in Bangladesh. It has started its production & Drag delivery from 1990. Eskayef Bangladesh Limited Tongi Plant is especially established for achieving the MHRA approval. For this reason, this unit provides the products with high quality. According to the training schedule we have visited all the departments of Eskayef Bangladesh Limited. The process of manufacturing & of maintaining qualities according to the cGMP guidelines were observed & in this light standard operating procedure (SOP) has been developed. All performances in the factory are highly documented.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
In-Plant Training ProgramAt
SK+F Eskayef Bangladesh Ltd.
Introduction
SK+F symbolizes a name-a state of mind. From the inception in 1990, it has today burgeoned into one of the top line conglomerates in Bangladesh. Eskayef Bangladesh Limited, the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1990 and is now on its way to becoming a high performance global player. Eskayef Bangladesh Limited is an organization with equal emphasis on Leadership, Technology, Quality & Passion.
Eskayef Bangladesh Limited is the leading generic pharmaceutical manufacturer in Bangladesh producing quality essential and other ethical drugs & medicines. Eskayef Bangladesh Limited has three GMP compliant formulation plants. The Tongi unit plant started its operation to meet challenges of globalization & to expand export horizon.Tongi plant is situated at Tongi, Gazipur. It is constructed as per the requirement of the UK MHRA. All the facilities and equipment have been designed and built to ensure cGMP compliance.
All facility is an excellent blend of modern architecture, advanced technology, quality assurance and professionalism. It enjoys its brilliant is the prominent Drag manufacturing company in Bangladesh. It has started its production & Drag delivery from 1990. Eskayef Bangladesh Limited Tongi Plant is especially established for achieving the MHRA approval. For this reason, this unit provides the products with high quality.
According to the training schedule we have visited all the departments of Eskayef Bangladesh Limited. The process of manufacturing & of maintaining qualities according to the cGMP guidelines were observed & in this light standard operating procedure (SOP) has been developed. All performances in the factory are highly documented.
Besides, Eskayef Bangladesh Limited providing local pharmaceutical needs & has been exporting its products to the many countries. It has been also receiving the order from the many Pharmaceutical Industry ( Tole Manufacturing ).
Eskayef Bangladesh Limited not only provide the high quality Drugs but also prevent the nature from its wastage affect. For this reason, it has established ETP plant which destroys the harmful effect of various toxic chemicals.
As a result of completing in-plant training in a well organized & well reputed company such as Eskayef Bangladesh Limited, our theoretical concept has become developed on the basis of practical view.
About Tongi Plant :
Area (Infrastructure):Total area of Tongi Plant is 39,000 square feet (approximate) and the capacity of Warehouse 7,34,000 square feet.
Manufacturing Dosage Facilities:
Tablet (Uncoated, Film Coated, Enteric Coated Tablet)CapsuleLiquidSachetTopical Preparation
HVAC System:
Total manufacturing area is under HVAC System.
Power Back up System:
Normally Electricity supplied from Dhaka Electric Supply Company (DESCO) & 24 hours back up power supply available through 03 Generators having capacity of 1250 KVA.
Purified Water System:
Water treatment plant have the capacity of 1000 Ltr./hr following Reverse Osmosis & UV Radiation Technology.
Current Plant Capacity:
Present production capacity in value is 120 Crore Taka & in unit packs 1.61 Crore Packs per year.
Waste Management System:
Have separate area for waste disposal under the supervision of the authorized person according to the standard operating procedure (SOP) following the direction of WHO guideline.Manufacturing Dosage Facilities:Tablet CapsuleEye dropVialDry Syrup
HVAC System:
Total manufacturing area is under HVAC System.
Power Back up System:
Captive own power supply from gas generator of 2.2 MW capacity which is back up by 800 KW diesel generator.
Purified Water System:
Water treatment plant has the capacity of 1000 Ltr./hr following Reverse Osmosis Technology and the capacity of WFI 800 kg / hr.
Distribution channel :
Transcom Distribution Co. Ltd. (TDLC) is the sole distributor of Eskayef products throughout Bangladesh.
Eskayef at a glance
Company name : Eskayef Bangladesh LimitedCompany logo :Company slogan : Excellence through qualityCompany type : Private limited companyAcquisition from : SmithKline & FrenchCompany started : 1990Ownership : Transcom groupFactories : Mirpur (generic), Tongi (generic & cepha)Marketing office : Taneem Square, Banani, DhakaCommercial Dept. : Taneem Square, Banani, DhakaInternational Business : Taneem Square, Banani, DhakaFinance & Accounts : Gulshan Tower, Gulshan 2, DhakaAHND office : Motijheel C/A, DhakaAnnual turnover : BDT 3000 million , US$ 44 millionWeb address : www.skfbd.comE-mail : [email protected] Director : Mr. A M FaruqueEmployees : 1500IMS ranking : 5th largest in Bangladesh Pharma IndustryPrime brand : Losectil (omeprazole)Business : Formulation, Consumer, Bulk Pellets, AHND
Distribution : Transcom Distribution Company Limited, TDCL
Depots : 20 DepotsRegions : 20 Regions
Vision & mission :
Eskayef envisions a leading role for itself as a catalyst for improvement of the healthcare environment.
The company's mission is to maintain people's health and combat disease to enhance the quality of human life so that people may live longer, healthier and more meaningful lives.Business :
Eskayef Bangladesh Ltd. started its operation with pharmaceutical finished products for the home market. Over time we have diversified our operations into bulk products as well as animal health and nutrition products.
Finished Products :
Backed by our strong technical and marketing teams we offer 149 products in 55 therapeutic segments.
Bulk Products :
We produce Timed Release Blended Pellets. Eskayef is the first and only pellet manufacturer in Bangladesh.
Animal Health and Nutrition Products :
We manufacture 28 animal health and nutrition products in 57 dosage forms and market them throughout Bangladesh.
Export :
Eskayef Bangladesh Ltd. has been showing a significant outcome in exporting medicines to many countries. Eskayef Bangladesh Ltd. has started supplying medicines in 16 countries like Germany, UAE, Nepal, Bhutan, Sri Lanka, Myanmar, Vietnam, Ghana, Iraq, Indonesia, Kenya, Guatemala, Belize, Yemen, Macau and Somalia.
Marketing of International Brands :
We are the sole agent in Bangladesh for marketing the ophthalmic products of Allergan Pharmaceuticals Ltd., Ireland in Bangladesh.
People :
The workforce of Eskayef consists of more than 1200 to 1500 appropriately qualified, trained and skilled personnel who are drawn from different disciplines that have a bearing on the pharmaceutical industry. Our team of dedicated professionals includes a panoply of pharmacists, medical graduates, microbiologists, chemists, engineers and business management experts. Their competencies, experience and strict adherence to the work ethic go into the manufacturing and marketing of each of the company's products.
Quality Approach
Our Total Quality System is our key strength. We have inherited the Standard Operating Procedures and Quality-Approach of SmithKline & French. Our WHO audited plants produce the products conforming to the highest international standards. And to maintain the excellence that we strive to achieve we use the most advanced technology for quality control and at each and every stage of the manufacturing process.
History:
The chairman of Transcom group planted a seed of dream in 1885. As the years went by the seed began to grow and soon turned into a full-grown tree with its leaves branching out in innumerable ventures. The company which started its business in the jute and tea sectors gradually diversified its operations into: Health care sectorHousehold electronic productsBeveragePrint mediaRestaurant franchiseSoftware, andDistribution ChannelToday, TRANSCOM is one of the leading conglomerate companies of the country. The dream has turned into reality by the pragmatic vision of Mr. Latifur Rahman, the Chairman of TRANSCOM GROUP and Eskayef Bangladesh Limited and the company proudly stands symbolizing the epic tree of the seed that was planted 120 years ago. Continuing its journey towards diversification, TRANSCOM entered the health care sector and acquired ownership of the world-renowned multinational pharmaceutical company SmithKline & French in the wake of the merger between SmithKline & French, USA and Beecham, UK in 1990. After the acquisition, the new company was styled - Eskayef Bangladesh Ltd and that has subsequently culminated under the bold and dynamic leadership of Mr. A M Faruque, the driving force and the Managing Director of Eskayef Bangladesh Limited.
Profile of MD
Mr. A M Faruque is the Managing Director of Eskayef Bangladesh Ltd., one of the top five pharmaceutical companies in Bangladesh. He started his pharmaceuticals career with Fisons Bangladesh Ltd. in 1974. In his long and illustrious career, he has also served in different positions in ICI, Hoechst, Smith Kline & French and Gulf Pharmaceuticals Industries, UAE. Mr. Faruque rejoined SK&F as Marketing Manager in the United Kingdom Overseas Group (UKOG), based at Welwyn Garden city, Hertfordshire, UK. After that he was relocated to the Bangladesh Smith Kline & French operation as their Marketing Manager till 1990, prior acquisition of the company by Transcom group, one of the leading conglomerate companies of Bangladesh.
Mr. Faruque started working at Eskayef Bangladesh Limited as a Plant Manager. Later on he served as the General
Manager and then the Executive Director of the company from till July 2004. Since July 15, 2004 he has been assigned with the responsibility of Managing Director of Eskayef Bangladesh Ltd. It is to be mentioned here that in the history of Bangladesh pharma market this is the first instance, where a private limited company, Eskayef, has appointed a Managing Director from the professional stratum.
Having started with a modest business of 1.20 crore taka in 1990, Eskayef Bangladesh Ltd. has now an annual turnover of 350 crore taka. This phenomenal growth was achieved under the bold and dynamic leadership of Mr. A M Faruque, the driving force and the navigator of Eskayef Bangladesh Limited. Keen to explore newer horizon, Mr. Faruque also has turned its focus on exporting the products. With its pioneering venture in international market with Nepal, Eskayef has expanded its business to Germany, UAE, Sri Lanka, Belize, Vietnam, Yemen and some other Central American countries.
True to his vision of offering world-class healthcare products, Mr. Faruque has undertaken a new project to expand its state-of-the-art pharmaceutical operations under the exclusive technical supervision of an UK pharmaceutical consultant. The new facility is being designed to conform to international cGMP with particular emphasis on meeting MHRA standards of the UK in order to facilitate exports to overseas markets.
Mr Faruque has obtained BSc (Hons) and MSc in Chemistry from Dhaka University. He has undergone an extensive training on marketing and sales force management in Ashridge Management College, UK.
Backed by our strong technical and marketing teams we offer 160 products in 59 therapeutic segments.
URITOL Tolterodine tartrate UROKIT Potassium citrate UROSIN Tamsulosin hydrochloride VEDILOL Carvedilol BP Coated Tablet VERON Mebeverine HCl VINCET Vinpocetine VIROXI Aciclovir VITRUM GOLD Multivitamin and multimineral Supplement VITRUM SILVER Multivitamins and Multimineralsl VOLMAX Diclofenac sodium XENOXIN Levofloxacin XENTHOL 30 Methyl salicylate 30% & Menthol 8% cream XINC Zinc sulfate XINC B Zinc and vitamin B complex ZATRAL Alfuzosine hydrochloride ZEEFOL Iron+Folic acid+Zinc ZEEFOL-CI Carbonyl iron, folic acid and zinc ZILVIT Zinc,carbonyl iron, folic acid, vitamin B complex and vitamin C ZITHROX Azithromycin dihydrate ZOFRA ODT Ondansetron
Warehouse : GenericDate :21.06.2010
Instructor : Shujib Biswas, Warehous Officer.
Key Service Benefits Of Warehouse :
Compliance
Fit for purpose facilitiesWritten Standard Operating ProceduresWarehouse personnel are trained in GWP Matters (hygiene, Protective clothing,handling Of Goods, computersystems And Preventativemaintenance Interface and computer systems validation
Increase productivity and efficiency
With an outsourced warehouse, we let you focus on your core business activities and reduce or eliminate your capital investment in non-core areas such as equipment and facilities.
Certainty and reliability
With a proven track record and an impressive customer portfolio, we will work to defined service levels to improve your entire supply chain.
A professional and progressive company, with the added partner resources of POD, Couriers Please, Star Track, Toll, Australia Post, Jet Express and more.
A complete, integrated solution
Supply chain management, leading edge technology and the most comprehensive distribution network available.
Responsive
Dedicated support personnel and regular service reviews ensure that our services continue to provide the best solution for your business needs. We’ll adapt as you grow.
1.Receiving Raw Materials : Receiving raw materials from approved source according to SOP.2. Storing Materials : Storing raw materials, finished goods and packaging materials.3. Dispensing : Dispensing raw materials, distributing packaging materials and loading finished products to the booth for marketing.
Central warehouse : warehouse-1 and warehouse-2
Source of RM :
Remo – Big Source Ganashasthya and Square Pharmaceuticals.
Dealing Documents :Receiving Record :Receiving Record No.Materials Name Batch No.Manufacturer SupplierQuantity Remarks BMR request form Manufacturing Order Finished Order
Central Warehouse : Unit- 01
Temperature : CRT ( 15-25 degree celcius )
Observation :
1.Sampling Booth : In Which sampling of raw materials is done.The following raw materials are available that were observed…Active :161Excipients : 160
2.Narcotic Station :
Stored according to govt. Regulations. The drugs that are stored in narcotic station are very much potent CNS stimulant and sometimes called controlled drugs.Stored in a locking system.Example : Dexpoten , Clonazepam, Pseudoephedrin ( Max. 3000 kg every year )
3. Capsule shell storing ( RH – 25-65% )Raw Materials Room Ext – 01: Active materials at CRT condition Raw Materials Room Ext – 02: Active materials at CRT condition Raw Materials Room Ext – 03: Active materials at CRT condition
Log book Cold room Temperature range : 2-8 degree celcius.Observed temperature : 5 degree celcius.Stored materials : Na frusitate, Benzyl alcohol, Injectables.
Cool roomTemperature range : 8-15 degree celcius.Observed temperature : 12 degree celcius.Stored Materials : Omeprazol E.C Pellates, Mg powder, Flavor’s, orange flavor powder, Essence, etc.
Shelf blockContains : Glass bottle, Plastic bottle, Raw materials that are not degraded in ambient conditions.
Solvent Room ( SR ) :
Temperature : AmbientStored Solvent :Methanol , Ethanol, Nitric Acid, HCl, isopropile alcohol, carbon tetrachloride, etc.
Room – 2126 :Simplifications : Waste disposal roomUtilization : For storing waste products with waste packaging materials
Production : Solid Dosage FormUnit : Manufacturing Unit – 02Date : 02.02.2010
Entering Procedure :
Instructor : Ishtiaq Ahmed, Asst. Manager, MU – 2
Wet granulation :Wet granulation is a process of using a liquid binder to lightly agglomerate the powder mixture. The amount of liquid has to be properly controlled, as over-wetting will cause the granules to be too hard and under-wetting will cause them to be too soft and friable. Aqueous solutions have the advantage of being safer to deal with than solvent-based systems.
Officers Chage Room
Shoe cover
Aprone and Head masking
Handirub Spraying
Procedure
Step 1: The active ingredient and excipients are weighed and mixed.Step 2: The wet granulate is prepared by adding the liquid binder–adhesive to the powder blend and mixing thoroughly. Examples of binders/adhesives include aqueous preparations of cornstarch, natural gums such as acacia, cellulose derivatives such as methyl cellulose, gelatin, and povidone.
Step 3: Screening the damp mass through a mesh to form pellets or granules.
Step 4: Drying the granulation. A conventional tray-dryer or fluid-bed dryer are most commonly used.
Step 5: After the granules are dried, they are passed through a screen of smaller size than the one used for the wet mass to create granules of uniform size.
Low shear wet granulation processes use very simple mixing equipment, and can take a considerable time to achieve a uniformly mixed state. High shear wet granulation processes use equipment that mixes the powder and liquid at a very fast rate, and thus speeds up the manufacturing process. Fluid bed granulation is a multiple-step wet granulation process performed in the same vessel to pre-heat, granulate, and dry the powders. It is used because it allows close control of the granulation process.
Dry granulation :
Dry granulation processes create granules by light compaction of the powder blend under low pressures. The compacts so-formed are broken up gently to produce granules (agglomerates). This process is often used when the product to be granulated is sensitive to moisture and heat. Dry granulation can be conducted on a tablet press using slugging tooling or on a roll press called a roller compactor. Dry granulation equipment offers a wide range of pressures to attain proper densification and granule formation. Dry granulation is simpler than wet granulation, therefore the cost is reduced. However, dry granulation often produces a higher percentage of fine granules, which can compromise the quality or create yield problems for the tablet. Dry granulation requires drugs or excipients with cohesive properties, and a 'dry binder' may need to be added to the formulation to facilitate the formation of granules.
Direct Compression :
The term “direct compression” is defined as the process by which tablets are compressed directly from powder mixture of API and suitable excipients. No pretreatment of the powder blend by wet or dry granulation procedure is required.
The events that motivates the industry people to use direct compression technique
I.Commercial availability of the directly compressible excipients possessing both good compressibility and good flowability.
II. Major advances in tablet compression machinery,i) Improved positive die feedingii) Precompression of powder blend
Merits
i)Direct compression is more efficient and economical process as compared to other processes, because it involves only dry blending and compaction of API and necessary excipients.
ii)The most important advantage of direct compression is economical process.Reduced processing time, reduced labor costs, fewer manufacturing steps, and less number of equipments are required, less process validation, reduced consumption of power.
iii)Elimination of heat and moisture, thus increasing not only the stability but also the suitability of the process for thermolabile and moisture sensitive API’s.
In case of directly compressed tablets after disintegration, each primary drug particle is liberated. While in the case of tablets prepared by compression of granules, small drug particles with a larger surface area adhere together into larger agglomerates; thus decreasing the surface area available for dissolution.
vi)The chances of batch-to-batch variation are negligible, because the unit operations required for manufacturing processes is fewer.
vii)Chemical stability problems for API and excipient would be avoided.viii)Provides stability against the effect of aging which affects the dissolution rates.
Merits over wet granulation process
The variables faced in the processing of the granules can lead to significant tableting problems. Properties of granules formed can be affected by viscosity of granulating solution, the rate of addition of granulating solution, type of mixer used and duration of mixing, method and rate of dry and wet blending. The above variables can change the density and the particle size of the resulting granules and may have a major influence on fill weight and compaction qualities. Drying can lead to unblending as soluble API migrates to the surface of the drying granules.
Room : P- 23Specifications : Wash Bay -2Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :Document
IPA for CleaningVim ( detergent )Jet
SalineClotechDetolGlass cleaner
Tablet coating
Many tablets today are coated after being pressed. Although sugar-coating was popular in the past, the process has many drawbacks. Modern tablet coatings are polymer and polysaccharide based, with plasticizers and pigments included. Tablet coatings must be stable and strong enough to survive the handling of the tablet, must not make tablets stick together during the coating process, and must follow the fine contours of embossed characters or logos on tablets. Coatings are necessary for tablets that have an unpleasant taste, and a smoother finish makes large tablets easier to swallow. Tablet coatings are also useful to extend the shelf-life of components that are sensitive to moisture or oxidation. Opaque materials like titanium dioxide can protect light-sensitive actives from photodegradation[citation needed]. Special coatings (for example with pearlescent effects) can enhance brand recognition.
If the active ingredient of a tablet is sensitive to acid, or is irritant to the stomach lining, an enteric coating can be used, which is resistant to stomach acid, and dissolves in the less acidic area of the intestines. Enteric coatings are also used for medicines that can be negatively affected by taking a long time to reach the small intestine, where they are absorbed. Coatings are often chosen to control the rate of dissolution of the drug in the gastrointestinal tract. Some drugs will be absorbed better at different points in the digestive system. If the highest percentage of absorption of a drug takes place in the stomach, a coating that dissolves quickly and easily in acid will be selected. If the rate of absorption is best in the large intestine or colon, then a coating that is acid resistant and dissolves slowly would be used to ensure it reached that point before dispersing. The area of the gastrointestinal tract with the best absorption for any particular drug is usually determined by clinical trials.
Room : P- 22Specifications : Coating -2Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Room P-17Specifications : Centrifugal Fluidized CoaterPressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
CF Coater :Id : T-04-013-002RPM : 100Capacity : 35 kgCoating time : Product dependent, around 1 hr.Volt : 400
Encapsulation Process :
When selecting the appropriate encapsulation process to meet customer objectives, Southwest Research Institute (SwRI) scientists, with collaborative support from clients, evaluate and balance a variety of performance and formulation criteria.
Microcapsule size is highly dependent on the process. The above graph illustrates general guidelines.
Encapsulation Process Selection CriteriaCore/shell material propertiesGas/liquid/solidSolubilityViscosity/surface tensionDensity
Specifications : Oven -02Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :Steam heated Oven
Id : T-04-025-002Origin : Indo GermanTemperature Range : 50-100 degree celcius
Room P-11
Specifications : Clean StorePressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Peppermint oilSieveContainerDrum
Room P-09
Specifications : IBS ( Intermediate bulk store )Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Container NPS : Fe sulfate, diclofenac , ascorbic acid, folic acidTablet : Tamen, Alben-DS, Solbion
Room P-10
Specifications : Wash bayPressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Various types machine washing
Room P-08
Specifications : IBS-1 ( Intermediate bulk store )Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :Container NPS : Fe sulfate, diclofenac , ascorbic acid, folic acidTablet : Tamen, Alben-DS, Solbion, etc.
Room P-01
Specifications : FBCPressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Fluidized Bed CoaterId : T-04-013-003Coating : Pelletes ( in operation )Operation : Coating and Drying concomitantly.
Peristaltic Pump
Specificity : For solution coatingId : T-04-061-003
Room P-02
Specifications : GranulationPressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
High Speed MixerId : T-04-036-001
Fluid Bed DryerId : T-04-031-001
Room P-03
Specifications : Coating -1Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Nicomac Coating SystemBrand : NicomacId : T-04-013-004Operation : All types of coating.Capacity : 450 kg.
Room P-05
Specifications : Blending -01Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Room P-06
Specifications : Blending -2Pressure Difference : 10-30 pas ( between corridor and room )Instrument and materials :
Gansons Multimill ( 1000 L )Double Cone BlenderNicomac Coating system ( 500 L )
Department : Quality ControlSite : Generic PortionStarting Date : 22 June, 2010
Ending Date : 24 June, 2010
Instructor : Kazi Mohammad Rafiqul Islam Sr. Officer , Analytical developmet.
Briefing ;
Assurance: The act of giving confidence, the state of being certain or the act of making certain.Quality assurance: The planned and systematic activities implemented in a quality system so that quality requirements for a product or service will be fulfilled.Control: An evaluation to indicate needed corrective responses; the act of guiding a process in which variability is attributable to a constant system of chance causes.Quality control: The observation techniques and activities used to fulfill requirements for quality.
GMP Quality Assurance and Compliance Procedures
How to Write Standard Operating Procedure All Documents - Classification, Definition and Approval Matrix GMP Quality Documentation Management and Change Control Documentation Rule for GMP Documents GMP Quality Documentation - Control, Tracking and Distribution Preparation, Maintenance and Change Control of Master Documents Pharmaceutical Deviation Report System Shelf Life of Product Vendor Selection and Evaluation Procedure Vendor Certification Procedure Pharmaceutical Product Complaint Procedure Annual Product Review Manufacturing Rework Procedure Responsibility of Authorized Person Procedure for Product Identification and Traceability GMP Audit Procedures Example of Checklist for Batch Documentation Evaluation of Batch Documentation and Release for Sale GMP Training Procedure How to Write GMP Training Materials House Keeping Audit Procedure Management and Control of Contract Work Criteria for Sourcing of Raw Materials, Critical Packaging Components and Imported Finished Goods Quality Concern Investigation Process
Analysis that are done :Raw materials analysisFinished products analysisStability analysis
From warehouse to QC :Commercial requisition Materials in warehousePreparing receiving record Sending it to QC Sampling completion Analysis in QC lab Passed Bill Paying to Manufacturer.
Potency Expression :As dried basis ( depending on LOD )As anhydrous basis ( depending on KFT ) As it is
Simple Calculation :
AB/DB = ( As it is *100 ) / (100-LOD/AB )
Stability Study :
Stability Chambers, Stability Rooms, and Environmental Chambers by Parameter Generation & Control.
Parameter Generation & Control (PGC) specializes in humidity control chambers and environmental chambers by providing precise relative humidity and temperature control with walk-in rooms, reach-in chambers, and relative humidity generators to serve existing structures. Precise humidity control systems are our specialty.
Our products include:
Stability chambers and stability rooms for the pharmaceutical industry that exceed ICH guidelines in regards to temperature and relative humidity control.Temperature humidity chambers and temperature/relative humidity generating units for mini-environments within the Semiconductor industry.
TAPPI rooms for the paper industry.
Environmental test chambers for temperature and relative humidity calibration utilizing chilled mirror technology.
Environmental chambers and environmental rooms for stress testing of products within various industries.
Relative humidity calibrations chambers to the Metrology industry for relative humidity and temperature sensor calibration.
WHO guideline :
25 degree celcius 60 % Relative Humidity ( Long Term-1 year, UK )30 degree celcius 70 % Relative Humidity ( Long Term-1 year, Asia )
Preparing RR Checking for quarantined Inspection For broken or torned If exposed in environment No need for sampling If not exposed in environment Sampling done. Materials in Sampling booth Appropriate Apparatus and hand masking Excipients sampling If bellow or equal 3 then all should be sampled If 3-100 then root over n+1 If Greater than 100 then 11 should be sampled Active ingredients Each bag should be Sampled.
Room : R-3Instruments :Laminar Air Flow ( LAF ) / Fume hood operator
Id : T-07-025-004Brand : MemmartOrigin :Temperature : 105-110 dcOperation time : 14.49 hr
Vacuum Oven :
Id : T-07-025-005Brand : MemmartOrigin :Temperature : 60-62 dcOperation time : 15.46 hr
Department : QCRoom : Packaging Materials
Instructor : Sabina
Checking of Packaging Materials :Design of MaterialsPrinting of MaterialsSupplierReceiving RecordSending RR to QCSampling Analysis in QC lab
Observation of Packaging Materials :
Paper :Art Card eg- OradinFinish BoardUV laminated glossy. eg- BonflexUV laminated mat . eg- AmbotonChromolax. Eg- AlbenOffset : Generally lifletArt Paper : usually for labeling.
Clean Ampoule :Generally PrintedType-1 Glass for preventing any sort of leachingTest : Heating at 90ºC +Titration with 0.2 N sulfuric acid
Amber Ampule :Printed Non printedTest : Heating at 90ºC +Titration with 0.2 N sulfuric acid
Plastic :Handerub bottleTest : Normal Water pouring test.
Sampling Booth :
Instructor : Tajul , QC Officer, Generic block
Period of Sampling :
=
Department : Quality ControlSub- Department : MicrobiologyDate :27.06.2010
Instructor : Sanowar, Microbiologist, Generic blockInstructs on :
Types of water :Portable waterSoft waterPurified waterWFISterile WFI
RR QC Data Entry
Log BookRR send to warehouse Sampling
Injectable Analysis :
Endotoxin test :
An endotoxin assay utilizing Limulus lysate (LAL) and a chromogenic peptide substrate is described. The assay of picograms of a compound, present in significant quantities almost everywhere, is obviously associated with a serious risk of contamination. Measures to avoid and detect contamination have been considered. When a quantitative assay like the present one is used, the inhibitory effects of samples analyzed are obvious and also possible to quantify. Methods to avoid such inhibitory effects have been studied and the simplest procedure seems to be dilution with endotoxin-free water, in some cases also combined with heat treatment (75 degrees C for 5 min).
Particulate matter test
Sterility test :
A sensitive sterility testing procedure for the detection of microbial contamination in petrolatum-based ointments is described. The method involves dissolving the ointment in filter-sterilized isopropyl myristate and filtering through a membrane filter. Improved sensitivity is obtained by blending the membrane in Trypticase Soy Broth before incubation. Filter-sterilized isopropyl myristate is shown to be less toxic to microorganisms than heat-sterilized isopropyl myristate. The isopropyl myristate method is more sensitive than the polyethylene glycol-ether method for the detection of microbial contamination.
The sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans (LRGs) and lipid A was tested by using commercially available and experimentally formulated LAL reagents. The glucans included two kinds of beta-(1,3)-D-glucans, laminarin and curdlan, and cellulosic material, LAL-reactive material (LAL-RM), extracted from a hollow-fiber (Cuprophan) hemodialyzer. LAL-RM loses its LAL activity when it is digested with cellulase and thus appears to be a beta-(1,4)-D-glucan or a mixed glucan containing a substantial proportion of beta-(1,4) linkages. All LAL reagents tested were at least 1,000-fold more sensitive to endotoxin than to LRGs. The presence of the surfactant Zwittergent was shown to interfere
with reactivity to LRGs; LAL reagents without added Zwittergent reacted more strongly to LRGs than did the same reagents containing Zwittergent. Chloroform extraction of LAL increased the reagents' sensitivity to both endotoxin and LRGs, but it was not responsible for LRG reactivity. The addition of Zwittergent significantly reduced the sensitivity of LAL reagents to lipid A. LAL without the surfactant was equally sensitive to endotoxin and lipid A. Both curdlan and LAL-RM amplified or enhanced the LAL response to endotoxin. Kinetic turbidimetric studies demonstrated that the enhancement was dependent on the glucan concentration.
Mode of Action of endotoxin :
The pathogenetic sequence of reactions mediated by endotoxin (LPS) leading to the production of sepsis involves the oxygen radicals or reactive oxygen species, which has been evaluated in the present review. Among reactive oxygen species hydroxyl radical either singly or in combination with peroxynitrite, produces tissue damage often observed during septic injury. Inactivation of these damaging radicals by antioxidants or nitric oxide inhibitor(s) may be helpful for protecting sepsis mediated derangements but the application of these agents as drugs in humans has not been fully successful. Transcription factor NF- B is reported to be the oxygen sensor in LPS induced endotoxemia. Polyphenols, especially the catechin group of compounds, are important therapeutic agents, which may be used for the treatment of endotoxin mediated sepsis. Observation of Microbiology Lab :BalanceSpecific Culture MediaFungal Culture MediaGrowth promotion testGrowth inhibiting testIncubator ( Memmert ) 16-22 dcConductometer ( Metrohm )PH meterLasir Particle measuring system ( Non viable )Air sampling Machine ( Viable )Systec V- 95 Autoclave ( Germany )Bi -septic Cabinet :For endotoxin testCulture PreparationSubculture Preparation Bio assayHVAC systemSterilizing Oven230 dc for 2 hrSometimes up to 14 days
Analytical DevelopmentDepartmentStarting Date : 29.06.2010
Filling from HopperNitrogen gas incorporating unitUpper sealing – 165 dcFinger for turningRoom Temperature : 19-25 dcRH : Up to 40%Rpm : 2400 sachet / hr
Sachet filling Machine – 02 :Brand : EnflexOrigine : SpainModel : F-14 DXRollerScalling Unit : Cutting at 140 ( 70/70 )Eye mark sensorLower sealing – 145 dcVertical sealing – 155 dcBatch Printer - 02Scizer - 02Vacuum Pump – 04Filling from Hopper - 02Nitrogen gas incorporating unitUpper sealing – 175 dcFinger for turning – 16 L + 36URoom Temperature : 19-25 dcRH : Up to 40%Rpm : 2400 sachet / hrCurrent volt : 370-390
Encapsulation Machine :Brand : Sejong – SF – 100Origin : KoreaShell in operation : 0,2,1Station : 12Holes in each station : 14Rpm : 65Operation : Zeefol – CI capsule
Documents Preserving :Soft entry Hard entryLog Book
Validation :
The ICH guidelines achieved a great deal in harmonising the definitions of the required validation characteristics and their basic requirements. However, they provide only a basis for a general discussion of the validation parameters, their calculation and interpretation. It is the responsibility of the analyst to identify parameters which are relevant to the performance of the given analytical procedure as well as to design proper validation protocols including acceptance criteria and to perform an appropriate evaluation.
In order to fulfil this resposibility properly, the background of the validation parameters and their consequences must be understood. In this part, the general concept of an integrated validation is discussed. The interdependencies to other ICH guidelines and topics during drug development (e.g. impurities and degradants, stability and specification design) must be taken into account to define the required acceptance criteria.
Evaluation of the results in order to prove the suitability of the analytical procedure must be based on the specification limits. Important parameters and aspects are discussed for the individual validation characteristics. In the following parts, these parameters will be discussed in detail. Examples will be given for their interpretation in order to facilitate the selection of parameters which are relevant to the performance and suitability of the given analytical procedure.
Classification of Validation :
Equipment Validation
Design Qualification ( DQ )Factory Acceptance Test ( FAT )Installation Qualification ( IQ )Operation Qualification ( OP )Performance Qualification ( PQ )
Method Validation
Test According to Controlled Direction
Three times Check : If Reproducible result, validated.
Process ValidationSame Process, Three timesIf reproducible result, validatedCleaning ValidationRange maintaining
Cleaning with purified waterInvolving ADLInvolving Microbiology
Four Ways of Validation :
Retrospective Validation ( After Commercial data, existing data analysis )Prospective Validation ( Before Commercialization, for new product )Concurrent Validation ( Market and Validation Concurrently ) Re- Validation ( Again Validity Check )
Waste water Pipe Equalization tank Alum + Lime +DAP + Uria
Primary settling tank
Aerated tank
Filter
Clarified tank
Filter
Upper part of water
Discharging
Sediment water
Condensed effluent
Pump
Drain
Sun light heating
Dried cake of sediment
Transferring dried sediment to outer zone
Water Boiller :400kg Steam / hr450- 500 dcAir Compressor :
Water Treatment Plant ( WTP )
Instructor : Abul Khair, Engineering Officer.
Purified Water Plant :
Water For Injection ( WFI ) :Instruments of WTP :System : Steel Mass, ItalyVessel : ChinaPipe : China
Ambient Air 8 kg Load / cm Cooling Unit
FilteringCompressed Air
Raw Water ( Heated )
Multi grade Filter
StorageTank ( 3000 L )
C- Grade Filter
Water Softener Unit ( Resin Column )
Cartridge Filter( 5 Micron )
Cartridge Filter( 3 Micron )
Soft Water Storage Tank
Reverse Osmosis( RO ) Membrane
Heat Exchanger
EDIPurified Water
Purified Water Heating Chamber( 100 dc )
Cooling Chamber( 25-30 dc )
Vartical 3 ColumnHeating At100 dc Again
WFI( 94 dc )
Water Loop System :
Purified Water :
PW Main Vessel ( 5000 L )PW Generic Distribution Vessel ( 2500 L )PW Cepha Block Distribution Vessel ( 2500 L )PW always in circulatory moment with 18 - 25 dc temperature.
Water For Injection :
WFI Main Vessel ( 5000 L )WFI Generic Distribution Vessel ( 2500 L )WFI Cepha Block Distribution Vessel ( 2500 L )WFI always in circulatory moment with above 85 dc temperature
Improved resolution of complex brain ganglioside mixtures was achieved by high-performance thin-layer chromatography. The percentage distribution of individual gangliosides was then determined by direct densitometric seanning, employing a transmittance mode, of the resorcinol-positive spots on the plate. As little as 90 pmol (29 ng) of lipid-bound sialic acid could be detected with a good signal-to-noise ratio. A linear detector response was observed up to 3.0 μg of lipid-bound sialic acid. The brain white matter ganglioside patterns of eight animal species, including human, chimpanzee, monkey, chicken, bovine, sheep, and pig, were examined in detail.
In addition, human brain gray matter, rat cerebral, rat brain gray matter, and rat cerebellar ganglioside patterns were also studied. Ganglioside GM4 (G7) was found to be one of the major components in primate and chicken brain white matter, but it represented only a minor ganglioside in other species. Other major gangliosides in all brain samples studied were GM1, GD1a, GD1b, and GT1b. GM1 was more abundant in white matter than in gray matter. GT1a, a recently discovered ganglioside species, was found in all species examined, but was most abundant in the rat cerebellum. The latter source also contained high proportions of GT1b and GQ1b.
Fourier Transform IR ( FTIR ) :
Biologically important apatite analogues have been examined by Fourier Transform Infrared Spectroscopy (FT-IR), and a method developed to quantitatively assess their crystalinity. Changes in the phosphate v1 and v3 regions, 900–1,200 cm-1, for a series of synthetic (containing hydroxide, fluoride, or carbonate ion) and biological apatites with crystal sizes of 100–200 A were analyzed with curve-fitting and second derivative spectroscopy. The v1,v3 contour was composed of three main subbands. Correlations were noted between two spectral parameters and crystal size as determined by x-ray diffraction. The percentage area of a component near 1,060 cm-1 decreased as the length of the c-axis of the hydroxyapatite (HA) compounds increased, while the frequency of a band near 1,020 cm-1 increased with increasing length of the apatite c-axis.
These parameters are thus proposed as indices of crystallinity for biological (poorly crystalline) HA. The FT-IR spectra of highly crystalline apatitic compounds were also analyzed. For crystal sizes of 200–450 A, the percentage area of the phosphate v1 band (near 960 cm-1) decreased with increasing HA crystal size. IR indices of crystallinity have thus been developed for both well crystallized and poorly crystallized HA derivatives. The molecular origins of the various contributions to the v1,v3 contour are discussed, and a
preliminary application of the method to a microscopic biological sample (rat epiphyseal growth plate) is illustrated.
Mainly for Identity
Peak against all functional groupBrand : ShimadzuOrigin : Japan
Polarimeter :Brand : PerkineimerOrigin : England
High Performance Liquid Chromatography ( HPLC ) :
Gas Chromatography ( GC ):Brand : ShimadzuOrigin : JapanGas UnitHead SpaceColumnGlass Column 300mPac ColumnDetectorFIDTCDSupporting UnitColumn Oven ( 500 dc )Inj. Port
Department : Quality ControlSub-Department : MicrobiologyDate : 11.07.2010
Tests That are Perfomed :Microbial Limit TestEndo toxin TestArea Qualification TestSterility TestWater AnalysisLAL Test
Instruments :
Bio septic Cabinet : 2Dynamic Pass BoxAutoclaveIncubator ( Memmert )
Sterilizing OvenKinetic LAL Analyzer ( BioTek )Double Door Autoclave ( Systec )Liquid Particle Counter ( Pamas, USA )Shaking Water Bath ( Germany ) Production Unit : Solid Dosage FormSite : Dedicated Cephalosporin PlantDate : 12.07.2010
Sound health is vital to our meaningful and worthwhile existence. In finding sustainable solutions to healthcare challenges, Eskayef is committed to improve the healthcare environment in Bangladesh by providing access to safe, effective and affordable medicines and related healthcare services to the people who need them.In order to prevent cross-contamination between products as well as to safeguard the workers' health and environmental safety, cephalosporin products must be manufactured in separate and dedicated self-contained areas with separate air handling facilities. True to its vision of offering world-class healthcare products, the new dedicated state-of-the-art cephalosporin plant has contructed under the exclusive technical supervision of one of the leading European pharmaceutical consultants.
This new facility is being designed to conform to international cGMP with particular emphasis
on meeting standards of the UK.Eskayef’s cephalosporin plantInfrastructureBuilding: » Basement : 10,500 sft (Store and Warehouse)» Ground floor : 11,400 sft (Change Room, Utility unit, Garment Washing Room, Material Receiving Unit, Training, Room, Library, Canteen etc)
» First floor : 11,400 sft (Production floor)» Second floor : 11,400 sft (Utility Unit, Quality Control Unit and Microbiological Laboratory Unit)
The dedicated cephalosporin plant has designed from Elomatic life science. All kinds of designs specially manufacturing specification, utility and production floor are designed by Elomatic life science, a renowned engineering and technical consultation services in Finland.Completely isolated from other facilities, independent facility.
HVAC (Heating, Ventilation & Air-Conditioning) system: Most upgraded world-class HVAC system is designed. Terminal HEPA (High Efficency Particulate Air) filters exist in all processessing areas.
The plant is completely auto-controlled by Central Building Management System (BMS) from Siemens.
Purified water, Water For Injection and Purified Steam system of European origin (Italy) are installed for cephalosporin products. Cold loop temperature is maintained <12°c. The entire production unit floor is composed of Self Leveling EPOXY coating with anitmicrobial component.
Captive power generator is available to guarantee uninterrupted power supply to the plant. Gas power generator- 2.4 MW is available in this plant.
Manufacturing equipments
Sourcing of most of the equipments for the facility is made from Europe with provisions for proper validation and to guarantee consistent performance and reliability.Vial lines including washing, sterilization, filling, labeling etc. complete operations are built up from European source (Italy). These systems also include auto weight control system.Autoclave and machinaries of dry powder for suspensions are also from European source (Italy).
UPGRADED WORLD-CLASS STANDARD HVAC SYSTEM
HVAC stands for "heating, ventilation and air-conditioning". The three functions of heating, ventilation and air-conditioning are closely interrelated. All seek to provide thermal comfort, acceptable indoor air quality, reasonable installation, operation and maintenance costs. HVAC systems can provide ventilation, reduce air infiltration and maintain pressure relationships between spaces.
Heating, ventilating and air-conditioning (HVAC) systems can play several roles to reduce the environmental impact of buildings. The primary function of HVAC systems is to provide
healthy and comfortable interior conditions for occupants; well-designed, efficient systems do this with minimal non-renewable energy and air and water pollutant emissions.
Heating: Heating systems may be classified as central or local. Central heating is often used in cold climates to heat private houses and public buildings. Such a system contains a boiler, furnace, or heat pump to heat water, steam, or air, all in a central location such as a furnace room in a home or a mechanical room in a large building. The system also contains piping or ductwork to distribute the heated fluid, and radiators to transfer this heat to the air. The radiators may be mounted on walls or buried in the floor to give under-floor heat.In boiler fed or radiant heating systems, all but the simplest systems have a pump to circulate the water and ensure an equal supply of heat to all the radiators.
The heated water can also be fed through another heat exchanger inside a storage cylinder to provide hot running water. Ventilation: Ventilation is the process of "changing" or replacing of air in any space to remove moisture, odors, smoke, heat, dust and airborne bacteria. Ventilation includes both the exchange of air to the outside as well as circulation of air within the building. It is one of the most important factors for maintaining acceptable indoor air quality in buildings.
Air-conditioning: An air conditioning system provides cooling, ventilation and humidity control for all or part of a house or building. The Freon or other refrigerant provides cooling through a process called the refrigeration cycle. The refrigeration cycle consists of four essential elements to create a cooling effect. A compressor provides compression for the system. This compression causes the cooling vapor to heat up. The compressed vapor is then cooled by heat exchange with the outside air, so that the vapor condenses to a fluid, in the condenser. The fluid is then pumped to the inside of the building, where it enters an evaporator. In this evaporator, small spray nozzles spray the cooling fluid into a chamber, where the pressure drops and the fluid evaporates. Since the evaporation absorbs heat form the surroundings, the surroundings cool off, and thus the evaporator absorbs or adds heat to the system. The vapor is then returned to the compressor. A metering device acts as a restriction in the system at the evaporator to ensure that the heat being absorbed by the system is absorbed at the proper rate.
Terminal HEPA (high efficiency particulate air) filters: HEPA filter is a type of high-efficiency air filter.
Function: HEPA filters can remove at least 99.97% of airborne particles 0.3 micrometres (µm) in diameter. Particles of this size are the most difficult to filter and are thus considered the most penetrating particle size (MPPS). Particles that are larger or smaller are filtered with even higher efficiency.
BUILDING MANAGEMENT SYSTEM (BMS)
Building Management System (BMS) is a high technology system installed on buildings that controls and monitors the building’s mechanical and electrical equipment such us air handling and cooling plant systems, lighting, power systems, fire systems, and security systems
building technologies are a leading supplier of products, systems and services for security, safety, comfort, eco-efficiency and economy in buildings.
PURIFIED WATER, WATER FOR INJECTION & PURIFIED STEAM SYSTEM
Purified water, water for injection and purified steam system are constructed by Stilmas, an Italian company specialized in the research, development and construction of the most advanced water treatment, distillation and purification plants, as well as ultra pure steam production systems in accordance with the latest guidelines and regulations set by FDA, cGMP and International Pharmacopoeias.
Water for Injection
Water for injection Purified water generation unit Purified steam systemCold loop temperature is maintained below 12°c, which ensures no microbiol growth.
SELF LEVELING EPOXY SURFACING
The production floor is made by self leveling EPOXY with anitmicrobial components in the entire process area. Self leveling epoxy (SLE) is a durable, cost-effective moderate duty floor surfacing that will provide a performance level in between a troweled surfacer and a protective coating.
Application:
Suited for painting the floor require it is very clean, beautiful, no dust and no bacterium. Also especially suited for the area that requires abrasion resistance, pressure resistance, impact resistance and anticorrosion such as production area, laboratory, office etc.
Key features:
Dust proof, wet proof, abrasion resistant and chemicals resistant.The surface is smooth and beautiful, easy to construct and maintain, with a little elasticity.Good adhesion, resistant to compress and impact.
Thickness: 3 mm.
CAPTIVE POWER GENERATION UNI
Captive power generator is available to guarantee uninterrupted power supply to the plant. Gas power generator- 2.4 MW is available in this plant.
Unit : Quality AssuranceSub- Unit : In-Process ControlSite : Cepha- BlockDate : 12.07.2010
Instructor : Responsibility :
Documentation PreservingEach Step checking in manufacturingLine clearance checking Finding out any sort of problemNon- Viable Particles CountSampling InspectionAnalysis of each COFA for each batchDeviation AnalysisOut of Specification ( OOS ) AnalysisRe working Procedure Batch history Documentation
QMS ( Quality Management System ) document :Participation of all personDeviation managementCorrective and Preventive action ( CAPA )Out of specification ( OOS )Rejection Audit and ReportingOOs Reporting & Investigation Form :DateSign of Dept. HeadNo. of OOSInvestigation
Deviation Reporting & Investigation form :
DateSign of Dept. HeadNo. of DeviationInvestigation
Investigation Analysis Recommendation of Head
HeadQA
Accepty/n
PreventiveMeasure
CAPA Correlation Date Selection &Follow up
Head of QA& Closing
Investigation Analysis Recommendation of Head
HeadQA
Accepty/n
PreventiveMeasure
CAPA Correlation Date Selection &Follow up
Head of QA& Closing
Change Control : Change in Controlled way Change Request form
Market Compliance Handling :
Rejection : Same Procedure is maintained
Auditing :
Internal Reporting :Vendor Auditing Record ( VAR )Assessment
External auditing :Should be Completed within 6 monthsMeeting in each monthFollow Up
Others Documentation :Validation ReportControl DirectionAnalytical Note BookLog BookCalibration RecordMaintenance RecordEnvironmental Monitoring RecordViable : Settle Plate, Finger print, Active air sampling, Soft sample Non Viable : Particles count of 0.5 & 5 micron size.